Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
Key Highlights
- ➤Illumina (ILMN) launches BioInsight Platform, its first unified software environment
- ➤DRAGEN v4.6 expands secondary analysis across supported cloud and standard CPU environments
- ➤Usage-based BioInsight Credits replace traditional annual subscriptions
- ➤Platform includes SpliceAI2, Illumina’s newly announced AI model for rare disease research
- ➤DRAGEN supports approximately 170 active Global Parkinson’s Genetics Program research projects
Expert Statements
Rami Mehio, Senior vice president and general manager of BioInsight at Illumina
“BioInsight was built on an incredible history of data, software, and AI innovation that Illumina has delivered in the industry for more than a decade”
Rami Mehio, Senior vice president and general manager of BioInsight at Illumina
“Now, BioInsight is accelerating our pace of innovation, and with the BioInsight Platform we are bringing customers one simple place to access the full breadth of our offerings across software, AI, and data.”
Rami Mehio, Senior vice president and general manager of BioInsight at Illumina
“And the best part is, we are only getting started.”
Rami Mehio, Senior vice president and general manager of BioInsight at Illumina
“Customers that use the BioInsight Platform will also have access to new capabilities in the future, empowering them to drive the next wave of biological insights for our industry.”
Andrew Singleton, Global Parkinson’s Genetics Program
“GP2 is driving research all around the world to investigate genetic risk and broaden our understanding of Parkinson’s disease.”
Andrew Singleton, Global Parkinson’s Genetics Program
“Software advances are crucial to help our researchers make sense of genetic data in a consistent, comprehensive, and scalable analysis environment.”
Andrew Singleton, Global Parkinson’s Genetics Program
“The combination of speed and scalability allows us to focus more on scientific questions and less on operational bottlenecks.”
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs PR Newswire
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight
Get started
Create a free account to read the full story.